{"id":2020,"date":"2015-03-25T17:52:09","date_gmt":"2015-03-25T16:52:09","guid":{"rendered":"http:\/\/allysonpollock.com\/?page_id=2020"},"modified":"2024-08-11T14:13:51","modified_gmt":"2024-08-11T13:13:51","slug":"pharmaceuticals-research","status":"publish","type":"page","link":"https:\/\/allysonpollock.com\/?page_id=2020","title":{"rendered":"Regulatory science and pharmaceuticals"},"content":{"rendered":"\n

Bogowicz P, Mehta A, Choudhary S … Pollock AM. Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study<\/a>. Journal of Pharmaceutical Policy and Practice. 2024;17:2372089. download<\/a><\/p>\n\n\n\n

Babatunde D, Pollock AM, Ocan M, et al. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus<\/a>. JRSM Open. 2024;15:20542704241232814. download<\/a><\/p>\n\n\n\n

Brhlikova P, Walker R, Fothergill-Misbah N, Pollock AM.<\/em> Bridging the treatment gap. World Neurology. 2023;38:14\u20135. download<\/a><\/p>\n\n\n\n

Brhlikova P, Mehta A, McGettigan P, Pollock AM, Roderick P, Farooqui HH. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics<\/a>. Journal of Pharmaceutical Policy and Practice. 2023;16:139. download<\/a><\/p>\n\n\n\n

Thakur DS, Reddy P. India\u2019s alarming \u2018fixed dose combination\u2019 problem<\/a>. The Hindu. 2023. download<\/a><\/p>\n\n\n\n

Brhlikova P, Persaud N, Osorio-de-Castro CGS, Pollock AM. Essential medicines lists are for high income countries too<\/a>. BMJ<\/em> 2023;382:e076783. download<\/a><\/p>\n\n\n\n

Brhlikova P, Deivanayagam TA, Babar Z-U-D, Osorio-de-Castro CGS, Caetano R, Pollock AM. Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation<\/a>. Journal of Pharmaceutical Policy and Practice 2023;16:88. download<\/a><\/p>\n\n\n\n

Green A, Lyus R, Ocan M, Pollock AM.<\/em> Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis<\/a>. J R Soc Med<\/em> 2023:01410768231181263. download<\/a><\/p>\n\n\n\n

Baldeh A-O, Millard C, Pollock AM, Brhlikova P.<\/em> Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda<\/a>. Journal of Pharmaceutical Policy and Practice<\/em> 2023;16:18. download<\/a><\/p>\n\n\n\n

Roderick P. Regulating new drugs in India needs to be improved<\/a>. The Lancet Regional Health – Southeast Asia<\/em> 2023;10. download<\/a><\/p>\n\n\n\n

Sevcikova P, Pollock AM. India jeopardizing \u2018pharmacy of the world\u2019 status.<\/a> Asia Times. 15 November 2022.<\/p>\n\n\n\n

Pollock AM, Sevcikova P. Unregulated \u2018innovation\u2019: India\u2019s medicine problem<\/a>. The Conversation. 14 November 2022. <\/p>\n\n\n\n

Mehta A, Brhlikova P, McGettigan P, Pollock AM, Roderick P, Farooqui, HH. Systemic antibiotic sales and WHO recommendations, India<\/a>. Bulletin of the World Health Organization Online First: 22 August 2022. download<\/a><\/p>\n\n\n\n

Pollock AM, Ocan M, Sevcikova P. East African countries should prioritise their essential medicines for drug registration<\/a>. The Conversation 18 Nov 2020.<\/p>\n\n\n\n

Lyus R, Pollock AM, Ocan M, Brhlikova P. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018<\/a>. Bulletin of the WHO 2020;98(8):530\u2013538. download<\/a><\/p>\n\n\n\n

Brhlikova P, Maigetter K, Murison J, Agaba AG, Tusiimire J, Pollock AM. Registration and local production of essential medicines in Uganda<\/a>. Journal of Pharmaceutical Policy and Practice 2020;13(1):31. download<\/a><\/p>\n\n\n

Rees C, Brhlikova P, Pollock AM. Will HPV vaccination prevent cervical cancer?<\/a> JRSM 2020. download<\/a><\/p>\n

Allan C, Joyce TJ, Pollock AM. Europe\u2019s new device regulations fail to protect the public<\/a>. BMJ. 2018 Oct 10;363:k4205. download<\/a><\/p>\n

Millard C. Essential medicines are missing from Maharashtra\u2019s pharmacies<\/a>. The Swaddle, 18 Mar 2018.
<\/span><\/p>\n

Evans V, Roderick P, Pollock AM. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India<\/a>. BMJ Global Health. 2018;3:e000263. download<\/a><\/span><\/p>\n

McGettigan P, Roderick P, Kadam A, Pollock AM. Threats to global antimicrobial resistance control; centrally approved and unapproved antibiotic formulations sold in India<\/a>. British Journal of Clinical Pharmacology. 2018\u00a0download<\/a><\/span><\/p>\n

Millard C, Kadam A, Mahajan R, Pollock AM, Brhlikova P. Availability of brands of six essential medicines in 124 pharmacies in Maharashtra<\/a>. Journal of Global Health. 2018;8(1). download<\/a><\/span><\/p>\n

McGettigan P, Pollock AM.\u00a0India not doing enough to stop sale of unapproved antibiotics<\/a>. Asia Times. 14 October 2017.<\/p>\n

Pollock AM, McGettigan P. Indian government not doing enough to tackle sale of unapproved antibiotics<\/a>. The Conversation. 13 Oct 2017.<\/span><\/p>\n

McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship<\/a>. The Lancet Global Health. 2017;5(11):e1075\u20136. download<\/a><\/span><\/p>\n

Ofori-Asenso R, Pollock AM, Brhlikova P. Poor prescription practices across Africa are putting patients at risk<\/a>. The Conversation 29 Aug 2016.<\/p>\n

Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995\u20132015)<\/a>. BMC Public Health. 2016;16:724. download<\/a><\/p>\n

Leng HJ, Sanders D. Who is to blame for the medicines backlog?<\/a> 31 Aug 2015.<\/p>\n

McGettigan P. India: the pharmacy of the world where \u2018crazy drug combinations\u2019 go unregulated<\/a>. The Conversation 20 July 2015.<\/p>\n

Leng HJ, Mutoti KP, Mbelle N. Regulatory requirements for the development and registration of biosimilars in South Africa<\/a>. GaBI Journal. 2015<\/p>\n

Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal<\/a>. Globalization and Health. 2015;11(25). download<\/a><\/p>\n

McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock, AM. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs<\/a>. PLoS Med. 2015;12(5):e1001826. download<\/a><\/p>\n

Millard C, Brhlikova P, Pollock AM. Social networks and health policy: the case of misoprostol and the WHO model essential medicine list<\/a>. Social Science & Medicine. 2015;132:190\u20136. download<\/a><\/p>\n

Maigetter K, Pollock AM, Kadam A, Ward K, Weiss MG. Pharmacovigilance in India, Uganda and South Africa with reference to WHO\u2019s minimum requirements<\/a>. Int J Health Policy Manag. 2015;4;5:295-305. download<\/a> dissemination video<\/a><\/p>\n

Leng HJ, Sanders D, Pollock AM. Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines<\/a>. GaBi Journal. 2015;4(2).<\/p>\n

Steele S, Freitag A, McGettigan P, Giovannoni G, Pollock AM. A guide to private prescribing<\/a>. Prescriber. 2015 Mar 19;19\u201323. download<\/a><\/p>\n

Atukunda, EC, Brhlikova P, Agaba AG, Pollock AM. Civil Society Organizations and medicines policy change: A case study of registration, procurement, distribution and use of misoprostol in Uganda<\/a>. Social Science & Medicine. 2015;130:242\u20139. download<\/a><\/p>\n

Evans V, Pollock AM. The proliferation of irrational metformin fixed-dose combinations in India<\/a>. The Lancet Diabetes and Endocrinology. 2015;3(2):98\u2013100. download<\/a><\/p>\n

Magadzire BP, Budden A, Ward K, Jeffery R, Sanders D. Frontline health workers as brokers: provider perceptions, experiences and mitigating strategies to improve access to essential medicines in South Africa<\/a>. BMC Health Services Research. 2014;14:520.<\/p>\n

Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al. The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice<\/a>. 2014;7(18). download<\/a><\/p>\n

Roderick P, Mahajan R, McGettigan P, Pollock AM. India should introduce a new Drugs A<\/a>ct<\/a>. The Lancet. 2014;383(9913):203\u20136. download<\/a><\/p>\n

Roderick P, Mahajan R, McGettigan P, Pollock AM, Jeffery R. Need for a new Drugs Bill<\/a>. Economic and Political Weekly. Mumbai; 2014 Aug 16;15\u20139. download<\/a><\/p>\n

Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme<\/a>. Bulletin of the WHO. 2014;92:482\u20139. download<\/a><\/p>\n

Millard C, Pollock AM, Brhlikova P. Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health<\/a>. BMJ. 2014;349:g4823. download<\/a><\/p>\n

McGettigan P, Pollock AM, Herxheimer A. MPs call for full results of all past clinical trials to be made public<\/a>. BMJ. 2014 Jan 3;348(jan03 1):g13\u2013g13.<\/p>\n

Atukunda EC, Brhlikova P, Agaba AG, Pollock AM. Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study<\/a>. The Lancet. 2013;382(Supplement 1):10. download<\/a><\/p>\n

Chinai R, Kadam A, Pollock AM, Jeffery R, Weiss MG, Mistry N. Access to medicines under India\u2019s National Disease Control Programmes: local study of TB, HIV and malaria medicines<\/a>. AMASA; 2013.<\/p>\n

Chinai R, Kadam A, Mahajan R, Pollock AM, Jeffery R, Maigetter K, et al. Inadequately enforced workforce planning norms undermine safety of Indian drugs<\/a>. AMASA; 2013.<\/p>\n

Chinai R, Kadam A, Mahajan R, McGettigan P, Pollock AM, Jeffery R, et al. \u2018Fixed Dose Combination\u2019 drugs and the case of Metformin<\/a>. AMASA; 2013.<\/p>\n

Chu CS, Brhlikova P, Pollock AM.\u00a0Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage<\/a>. JRSM. 2012;105:336\u201347.\u00a0download<\/a><\/p>\n

Mattheij I, Pollock A, Brhlikova P. Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness<\/a>. JRSM<\/em> 2012;105:250\u201362. download<\/a><\/p>\n

Pollock AM, Brhlikova P, Mattheij I. Author\u2019s Response: HPV vaccination in India<\/a>. JRSM<\/em> 2012;105:366\u20137. download<\/a><\/p>\n

Pollock A, Brhlikova P, McGettigan P. Reviewer\u2019s commentary on \u2018Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence<\/a>\u2019. BJOG\u202f: an international journal of obstetrics and gynaecology<\/em> 2012;:11. download<\/a><\/p>\n

Roderick P, Pollock A. India\u2019s patent laws under pressure<\/a>. The Lancet<\/em> 2012;380:e2\u2013e4. download<\/a><\/p>\n

Richardson E, Pollock A. Community pharmacy: moving from dispensing to diagnosis and treatment<\/a>. BMJ<\/em> 2010;340:c2298. download<\/a><\/p>\n

Pollock AM, Price D. Briefing on the specification of pharmaceutical product defects. Centre for International Public Health Policy 2009. download<\/a><\/p>\n

Pollock AM, Kerrison S, McNally N. Best research<\/a>. BMJ<\/em> 2006;332:247\u20138. download<\/a><\/p>\n

Kerrison S, Pollock AM. The reform of UK research ethics committees: throwing the baby out with the bath water? Journal of Medical Ethics<\/em> 2005;31:487\u20139. download<\/a><\/p>\n

Kerrison S, McNally N, Pollock AM. United Kingdom research governance strategy: Authors\u2019 reply<\/a>. BMJ<\/em> 2004;328:50\u201350. download<\/a><\/p>\n

Kerrison S, McNally N, Pollock A. United Kingdom research governance strategy<\/a>. BMJ<\/em> 2003;327:553\u20136. download<\/a><\/p>\n

McNally N, Kerrison S, Pollock A. Reforming clinical research and development in England<\/a>. BMJ<\/em> 2003;327:550\u20133. download<\/a><\/p>\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Bogowicz P, Mehta A, Choudhary S … Pollock AM. Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study. Journal of Pharmaceutical Policy and Practice. 2024;17:2372089. download Babatunde D, Pollock AM, Ocan M, et al. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"footnotes":""},"tags":[],"class_list":["post-2020","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages\/2020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2020"}],"version-history":[{"count":0,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages\/2020\/revisions"}],"wp:attachment":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2020"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}